Roche VP-Sales & Marketing Senich Joins From Medco
This article was originally published in The Pink Sheet Daily
Senich will lead several departments including account management and state government affairs. At Merck-Medco, she led marketing strategy development and implementation for Fosamax worldwide and for the company's cholesterol franchise in the U.S.
You may also be interested in...
FDA’s draft guidance on systemic lupus erythematosus drug development lists four possible claims that the agency “may be willing to approve”: reduction in disease activity; organ-specific lupus treatment; complete clinical response/remission; and reduction in flares.
Three FDA risk management final guidances recommend that sponsors collect a wide range of safety data during both the clinical trial and postmarketing periods of drug development. The agency suggests that sponsors hold discussions with FDA before settling on drug study designs or postmarketing activities.
FDA is planning to develop a Risk Minimization Action Plan website, an agency risk management guidance states